Authors:
FOUNTZILAS G
ATHANASSIADIS A
NIKOLAOU A
KALOGERAFOUNTZILA A
TZITZIKAS J
SAMANTAS E
SKARLOS D
ZAMBOGLOU N
DANIILIDIS J
Citation: G. Fountzilas et al., ACCELERATED BIFRACTIONATED RADIATION WITH CONCURRENT CISPLATIN ADMINISTRATION IN LOCALLY ADVANCED HEAD AND NECK-CANCER - A FEASIBILITY STUDY, Tumori, 83(4), 1997, pp. 735-739
Authors:
FOUNTZILAS G
VASILAROS S
KOUKOURAS D
MALAMOS N
PECTASIDES D
ADAMOU A
NENOPOULOU E
KIRIAKOU K
ZOUVANI I
KATSOHIS K
KAPPAS A
SKOPA C
SEMOGLOU C
FAHANTIDIS E
KONSTANTARAS C
VASILAKI E
ECONOMOPOULOS T
BACOYIANNIS H
BAFALOUKOS D
RAZI E
POLICHRONIS A
ANDROULAKIS G
PAPAIOANNOU T
PAVLIDIS N
SKARLOS D
KOSMIDIS P
Citation: G. Fountzilas et al., PROGNOSTIC VARIABLES IN CREEK PATIENTS WITH STAGE-II BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Anticancer research, 17(6D), 1997, pp. 4681-4689
Authors:
TSAVARIS N
PRIMIKIRIOS N
MYLONAKIS N
VAROUCHAKIS G
DOSIOS T
PAVLIDIS N
SKARLOS D
TASOPOULOS T
DRITSAS J
KOSMIDIS P
Citation: N. Tsavaris et al., COMBINATION CHEMOTHERAPY WITH CISPLATIN AND OR DOXORUBICIN IN MALIGNANT MESOTHELIOMA - A PROSPECTIVE-STUDY/, Anticancer research, 17(5B), 1997, pp. 3799-3802
Authors:
FOUNTZILAS G
KOSMIDIS P
AVRAMIDIS V
NIKOLAOU A
KALOGERAFOUNTZILA A
MAKRANTONAKIS P
BACOYIANNIS C
SAMANTAS E
SKARLOS D
DANIILIDIS J
Citation: G. Fountzilas et al., LONG-TERM SURVIVAL-DATA AND PROGNOSTIC FACTORS OF A COMPLETE RESPONSETO CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK-CANCER TREATED WITH PLATINUM-BASED INDUCTION CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Medical and pediatric oncology, 28(6), 1997, pp. 401-410
Authors:
FOUNTZILAS G
ATHANASSIADES A
KALOGERAFOUNTZILA A
SAMANTAS E
BACOYIANNIS C
BRIASSOULIS E
PAVLIDIS N
KOSMIDIS P
SKARLOS D
Citation: G. Fountzilas et al., PACLITAXEL IN COMBINATION WITH CARBOPLATIN OR GEMCITABINE FOR THE TREATMENT OF ADVANCED HEAD AND NECK-CANCER, Seminars in oncology, 24(6), 1997, pp. 28-32
Authors:
KOSMIDIS P
MYLONAKIS N
FOUNTZILAS G
SAMANTAS E
ATHANASSIADIS A
PAVLIDIS N
SKARLOS D
Citation: P. Kosmidis et al., PACLITAXEL (175 MG M(2)) PLUS CARBOPLATIN VERSUS PACLITAXEL (225 MG/M(2)) PLUS CARBOPLATIN IN NONSMALL CELL LUNG-CANCER - A RANDOMIZED STUDY/, Seminars in oncology, 24(4), 1997, pp. 30-33
Authors:
FOUNTZILAS G
ATHANASSIADIS A
SAMANTAS E
SKARLOS D
KALOGERAFOUNTZILA A
NIKOLAOU A
BACOYIANNIS H
STATHOPOULOS G
KOSMIDIS P
DANIILIDIS J
Citation: G. Fountzilas et al., PACLITAXEL AND CARBOPLATIN IN RECURRENT OR METASTATIC HEAD AND NECK-CANCER - A PHASE-II STUDY, Seminars in oncology, 24(1), 1997, pp. 65-67
Authors:
FOUNTZILAS G
ATHANASSIADES A
GIANNAKAKIS T
BAFALOUKOS D
KARAKOUSIS K
DOMBROS N
KOSMIDIS P
SKARLOS D
Citation: G. Fountzilas et al., A PHASE-II STUDY OF PACLITAXEL IN ADVANCED BREAST-CANCER RESISTANT TOANTHRACYCLINES, European journal of cancer, 32A(1), 1996, pp. 47-51
Authors:
KOSMIDIS P
MYLONAKIS N
FOUNTZILAS G
PAVLIDIS N
SAMANTAS E
KARABELIS A
KATTIS K
SKARLOS D
Citation: P. Kosmidis et al., A PROSPECTIVE RANDOMIZED PHASE-III STUDY IN NON-SMALL-CELL LUNG-CANCER COMPARING CISPLATIN, IFOSFAMIDE, VINBLASTINE (VIP) VERSUS CISPLATIN,IFOSFAMIDE AND ETOPOSIDE (VIP-16), Annals of oncology, 7(5), 1996, pp. 517-520
Authors:
FOUNTZILAS G
KOSMIDIS P
SRIDHAR KS
KALOGERAFOUNTZILA A
BANIS K
DIMITRIADIS A
AVRAMIDIS V
NIKOLAOU A
ZARAMBOUKAS T
SKARLOS D
VRITSIOS A
DANIILIDIS I
Citation: G. Fountzilas et al., CISPLATIN AND CONTINUOUS-INFUSION OF FLUOROURACIL FOLLOWED BY RADIATION AND WEEKLY CARBOPLATIN IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Cancer investigation, 14(3), 1996, pp. 189-196
Authors:
KOSMIDIS PA
TSAVARIS N
SKARLOS D
THEOCHARIS D
SAMANTAS E
PAVLIDIS N
BRIASSOULIS E
FOUNTZILAS G
Citation: Pa. Kosmidis et al., FLUOROURACIL AND LEUCOVORIN WITH OR WITHOUT INTERFERON ALFA-2B IN ADVANCED COLORECTAL-CANCER - ANALYSIS OF A PROSPECTIVE RANDOMIZED PHASE-III TRIAL, Journal of clinical oncology, 14(10), 1996, pp. 2682-2687
Authors:
BAFALOUKOS D
PAVLIDIS N
FOUNTZILAS G
SKARLOS D
KLOUVAS G
MAKRANTONAKIS P
GIANNAKAKIS T
TSAVARIS N
KOSMIDIS P
Citation: D. Bafaloukos et al., RECOMBINANT INTERFERON ALFA-2A IN COMBINATION WITH CARBOPLATIN, VINBLASTINE, AND BLEOMYCIN IN THE TREATMENT OF ADVANCED MALIGNANT-MELANOMA, American journal of clinical oncology, 19(3), 1996, pp. 296-300
Authors:
FOUNTZILAS G
GOSSIOS K
ZISIADIS A
SVARNA E
SKARLOS D
PAVLIDIS N
Citation: G. Fountzilas et al., PROGNOSTIC VARIABLES IN PATIENTS WITH ADVANCED COLORECTAL-CANCER TREATED WITH FLUOROURACIL AND LEUCOVORIN-BASED CHEMOTHERAPY, Medical and pediatric oncology, 26(5), 1996, pp. 305-317
Authors:
FOUNTZILAS G
KATSOHIS K
TOUSSIS D
KOSMIDIS P
SEMOGLOU C
FAHANTIDIS E
TSAVARIS N
MAKRANTONAKIS P
ZAMBOGLOU N
HAINOGLOU D
PAVLIDIS N
POLICHRONIS A
GENNATAS K
SKARLOS D
VASSILAROS S
GIANNAKAKIS T
KLOUVAS G
KONSTANTARAS C
KOLOTAS C
TSILIAKOS S
MYLONAKIS N
Citation: G. Fountzilas et al., CYCLOPHOSPHAMIDE, MITOXANTRONE, FLUOROURACIL VERSUS CONVENTIONAL CMF AS ADJUVANT TREATMENT IN NODE-POSITIVE BREAST-CANCER PATIENTS - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 53(2), 1996, pp. 137-146
Authors:
PAVLIDIS N
NICOLAIDES C
ATHANASSIADIS A
BERIATOU K
SKARLOS D
GIANNAKAKIS T
KOSMIDIS P
KARVOUNIS N
FOUNTZILAS G
Citation: N. Pavlidis et al., PHASE-II STUDY OF 5-FLUOROURACIL AND INTERFERON-GAMMA IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 53(2), 1996, pp. 159-162
Authors:
FOUNTZILAS G
SKARLOS D
ATHANASSIADIS A
NIKOLAIDES C
GIANNAKAKIS T
BAFALOUKOS D
PAPAKOSTAS P
STATHOPOULOS G
KOSMIDIS P
PAVLIDIS N
Citation: G. Fountzilas et al., INTENSIFIED ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH BREAST-CANCER ANDLESS-THAN-10 POSITIVE LYMPH-NODES - A PHASE-II STUDY, European journal of cancer, 31A, 1995, pp. 69-69
Authors:
GIANNAKAKIS T
SKARLOS D
ATHANASIADES A
FOUNTZILAS G
BAFALOUKOS D
KOSMIDIS P
NIKOLAIDES K
PAVLIDIS N
Citation: T. Giannakakis et al., A RANDOMIZED STUDY COMPARING ONDANSETRON (OND) WITH ONDANSETRON PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) RECEIVING HIGH-DOSE EPIRUBICIN (HDE) - PRELIMINARY-REPORT, European journal of cancer, 31A, 1995, pp. 1235-1235
Authors:
FOUNTZILAS G
SKARLOS D
NIKOLAOU A
KALOGERAFOUNTZILA A
TZITZIKAS J
KOSMIDIS P
MAKRANTONAKIS P
SAMANTAS E
KARPASITIS N
BACOYIANNIS H
SYNODINOU M
PAVLIDIS N
VRITSIOS A
DANILLIDIS J
Citation: G. Fountzilas et al., RADIATION AND CONCURRENT CARBOPLATIN ADMINISTRATION IN LOCALLY ADVANCED HEAD AND NECK-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Tumori, 81(5), 1995, pp. 354-358
Authors:
SIVOLAPENKO GB
DOULI V
PECTASIDES D
SKARLOS D
SIRMALIS G
HUSSAIN R
COOK J
COURTENAYLUCK NS
MERKOURI E
KONSTANTINIDES K
EPENETOS AA
Citation: Gb. Sivolapenko et al., BREAST-CANCER IMAGING WITH RADIOLABELED PEPTIDE FROM COMPLEMENTARITY-DETERMINING REGION OF ANTITUMOR ANTIBODY, Lancet, 346(8991-2), 1995, pp. 1662-1666
Authors:
FOUNTZILAS G
SKARLOS D
KATSOHIS C
PAVLIDIS N
GIANNAKAKIS T
BAFALOUKOS D
FAHANTIDIS E
KLOUVAS G
BEER M
KOSMIDIS P
Citation: G. Fountzilas et al., HIGH-DOSE EPIRUBICIN AND R-MET-HU G-CSF (FILGRASTIM) IN THE TREATMENTOF PATIENTS WITH ADVANCED BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Medical and pediatric oncology, 24(1), 1995, pp. 23-28
Authors:
FOUNTZILAS G
SKARLOS D
GIANNAKAKIS T
ATHANASIADES A
BAFALOUKOS D
KALOGERAFOUNTZILA A
BAMIA C
PAVLIDIS N
KOSMIDIS P
Citation: G. Fountzilas et al., INTENSIVE CHEMOTHERAPY WITH HIGH-DOSE EPIRUBICIN EVERY 2 WEEKS AND PROPHYLACTIC ADMINISTRATION OF FILGRASTIM IN ADVANCED BREAST-CANCER, European journal of cancer, 30A(7), 1994, pp. 965-969
Authors:
FOUNTZILAS G
SKARLOS D
KOSMIDIS P
SAMANTAS E
KALOGERAFOUNTZILA A
PAPASPYROU S
TZITZIKAS J
SRIDHAR KS
MAKRANTONAKIS P
PANTELAKOS P
NIKOLAOU A
BACOYIANNIS H
SINODINOU M
BANIS C
DANIILIDIS J
Citation: G. Fountzilas et al., RADIATION-THERAPY AND CONCURRENT CISPLATIN ADMINISTRATION IN LOCALLY ADVANCED HEAD AND NECK-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Acta oncologica, 33(7), 1994, pp. 825-830
Authors:
KIRIAKOGIANIPSAROPOULOU P
MALAMOUMITSI V
MARTINOPOULOU U
LEGAKI S
TAMVAKIS N
VRETTOU E
FOUNTZILAS G
SKARLOS D
KOSMIDIS P
PAVLIDIS N
Citation: P. Kiriakogianipsaropoulou et al., THE VALUE OF NEUROENDOCRINE MARKERS IN NONSMALL CELL LUNG-CANCER - A COMPARATIVE IMMUNOHISTOPATHOLOGIC STUDY, Lung cancer, 11(5-6), 1994, pp. 353-364